• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Measurement of regional cerebral glucose utilization with fluorine-18-FDG and PET in heterogeneous tissues: theoretical considerations and practical procedure.

作者信息

Lucignani G, Schmidt K C, Moresco R M, Striano G, Colombo F, Sokoloff L, Fazio F

机构信息

INB-CNR, Department of Nuclear Medicine University of Milan, Institute H. San Raffaele, Italy.

出版信息

J Nucl Med. 1993 Mar;34(3):360-9.

PMID:8441024
Abstract

Functional tissue heterogeneity, i.e., inclusion of tissues with different rates of blood flow and metabolism within a single region of interest, is an unavoidable problem with PET. Errors in determination of regional cerebral glucose utilization (rCMRglc) with [18F]FDG have resulted from the currently used simplifying assumption that all regions examined are homogeneous. We have established an optimal, yet practical procedure to minimize errors due to tissue heterogeneity in determination of rCMRglc. Effects of applying the three-rate constant kinetic model designed for homogeneous tissues with both dynamic and single-scan procedures and the Patlak plot were evaluated in normal subjects in experimental periods up to 120 min following tracer injection. The procedure with a single scan carried out any time within the interval between 60 and 120 min following tracer injection, combined with population average rate constants determined over a 120-min period, was found to be optimal for quantitative rCMRglc studies.

摘要

相似文献

1
Measurement of regional cerebral glucose utilization with fluorine-18-FDG and PET in heterogeneous tissues: theoretical considerations and practical procedure.
J Nucl Med. 1993 Mar;34(3):360-9.
2
Errors introduced by tissue heterogeneity in estimation of local cerebral glucose utilization with current kinetic models of the [18F]fluorodeoxyglucose method.在使用当前[18F]氟脱氧葡萄糖法动力学模型估计局部脑葡萄糖利用时,组织异质性所引入的误差。
J Cereb Blood Flow Metab. 1992 Sep;12(5):823-34. doi: 10.1038/jcbfm.1992.114.
3
Regional kinetic constants and cerebral metabolic rate for glucose in normal human volunteers determined by dynamic positron emission tomography of [18F]-2-fluoro-2-deoxy-D-glucose.通过[18F]-2-氟-2-脱氧-D-葡萄糖的动态正电子发射断层扫描测定正常人类志愿者的区域动力学常数和脑葡萄糖代谢率。
J Cereb Blood Flow Metab. 1984 Jun;4(2):212-23. doi: 10.1038/jcbfm.1984.30.
4
Cerebral glucose metabolic rates after 30 and 45 minute acquisitions: a comparative study.30分钟和45分钟采集后的脑葡萄糖代谢率:一项比较研究。
J Nucl Med. 1992 Dec;33(12):2103-5.
5
Two behavioral states studied in a single PET/FDG procedure: theory, method, and preliminary results.在一次正电子发射断层显像/氟代脱氧葡萄糖(PET/FDG)检查中研究的两种行为状态:理论、方法及初步结果。
J Nucl Med. 1987 May;28(5):852-60.
6
Effect of selecting a fixed dephosphorylation rate on the estimation of rate constants and rCMRGlu from dynamic [18F] fluorodeoxyglucose/PET data.从动态[18F]氟代脱氧葡萄糖/PET数据中选择固定的去磷酸化速率对速率常数和rCMRGlu估计的影响。
J Nucl Med. 1989 Sep;30(9):1483-8.
7
Measurements of glucose phosphorylation with FDG and PET are not reduced by dephosphorylation of FDG-6-phosphate.使用氟代脱氧葡萄糖(FDG)和正电子发射断层扫描(PET)对葡萄糖磷酸化进行的测量不会因FDG-6-磷酸的去磷酸化而降低。
J Nucl Med. 1991 Apr;32(4):692-8.
8
Determination of regional rate constants from dynamic FDG-PET studies in Parkinson's disease.从帕金森病的动态氟代脱氧葡萄糖正电子发射断层扫描研究中确定区域速率常数。
J Nucl Med. 1996 Jul;37(7):1115-22.
9
Human cerebral glucose metabolism determined by positron emission tomography: a revisit.正电子发射断层扫描测定的人脑葡萄糖代谢:再探讨
J Cereb Blood Flow Metab. 1987 Aug;7(4):427-32. doi: 10.1038/jcbfm.1987.86.
10
Effects of percent thresholding on the extraction of [18F]fluorodeoxyglucose positron emission tomographic region-of-interest data.百分比阈值化对[18F]氟脱氧葡萄糖正电子发射断层扫描感兴趣区域数据提取的影响。
J Cereb Blood Flow Metab. 1991 Mar;11(2):A83-8. doi: 10.1038/jcbfm.1991.42.

引用本文的文献

1
Automated extraction of the arterial input function from brain images for parametric PET studies.用于参数化PET研究的从脑图像中自动提取动脉输入函数
EJNMMI Res. 2024 Apr 1;14(1):33. doi: 10.1186/s13550-024-01100-x.
2
A short F-FDG imaging window triple injection neuroimaging protocol for parametric mapping in PET.一种用于PET参数映射的短F-FDG成像窗口三重注射神经成像方案。
EJNMMI Res. 2024 Jan 2;14(1):1. doi: 10.1186/s13550-023-01061-7.
3
2DG and glycolysis as therapeutic targets for status epilepticus.2-脱氧-D-葡萄糖和糖酵解作为癫痫持续状态的治疗靶点。
Epilepsy Behav. 2023 Mar;140:109108. doi: 10.1016/j.yebeh.2023.109108. Epub 2023 Feb 16.
4
EANM procedure guidelines for brain PET imaging using [F]FDG, version 3.EANM 脑 PET 成像使用[F]FDG 规程指南,第 3 版。
Eur J Nucl Med Mol Imaging. 2022 Jan;49(2):632-651. doi: 10.1007/s00259-021-05603-w. Epub 2021 Dec 9.
5
Assessment of population-based input functions for Patlak imaging of whole body dynamic F-FDG PET.基于人群的输入函数在全身动态F-FDG PET的Patlak成像中的评估。
EJNMMI Phys. 2020 Nov 23;7(1):67. doi: 10.1186/s40658-020-00330-x.
6
Joint EANM/EANO/RANO practice guidelines/SNMMI procedure standards for imaging of gliomas using PET with radiolabelled amino acids and [F]FDG: version 1.0.EANM/EANO/RANO 联合实践指南/SNMMI 程序标准:使用放射性标记氨基酸和 [F]FDG 的脑胶质瘤 PET 成像:第 1.0 版。
Eur J Nucl Med Mol Imaging. 2019 Mar;46(3):540-557. doi: 10.1007/s00259-018-4207-9. Epub 2018 Dec 5.
7
A virtual clinical trial comparing static versus dynamic PET imaging in measuring response to breast cancer therapy.一项比较静态与动态PET成像在测量乳腺癌治疗反应中的虚拟临床试验。
Phys Med Biol. 2017 May 7;62(9):3639-3655. doi: 10.1088/1361-6560/aa6023. Epub 2017 Feb 13.
8
Effect of F-FDG uptake time on lesion detectability in PET imaging of early stage breast cancer.F-FDG摄取时间对早期乳腺癌PET成像中病变可检测性的影响。
Tomography. 2015 Sep;1(1):53-60. doi: 10.18383/j.tom.2015.00151.
9
Generalized whole-body Patlak parametric imaging for enhanced quantification in clinical PET.用于临床PET中增强定量分析的全身广义Patlak参数成像。
Phys Med Biol. 2015 Nov 21;60(22):8643-73. doi: 10.1088/0031-9155/60/22/8643. Epub 2015 Oct 28.
10
Multicenter Clinical Trials Using 18F-FDG PET to Measure Early Response to Oncologic Therapy: Effects of Injection-to-Acquisition Time Variability on Required Sample Size.使用18F-FDG PET测量肿瘤治疗早期反应的多中心临床试验:注射至采集时间变异性对所需样本量的影响。
J Nucl Med. 2016 Feb;57(2):226-30. doi: 10.2967/jnumed.115.162289. Epub 2015 Oct 22.